Arrowstreet Capital
PHVS icon

Arrowstreet Capital’s Pharvaris PHVS Stock Holding History

Arrowstreet Capital’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
+29,313
New +$887K ﹤0.01% 1642

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Arrowstreet Capital's PHVS Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Pharvaris (PHVS) in Q2 2026: 29,313 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #1642 among its holdings.

125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Arrowstreet Capital held 29,313 shares of Pharvaris worth $1.01M as of Q2 2026.
  • Pharvaris was a new Arrowstreet Capital position in Q2 2026.
  • Pharvaris made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1642 holding.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.